{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T01:58:56Z","timestamp":1794967136628,"version":"4.9.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Dilated cardiomyopathy (DCM) is a leading cause of heart failure, often resulting in reduced ejection fraction and progressive cardiac dysfunction. Although up to half of idiopathic DCM can be linked to genetic variants, many familial cases still lack a definitive molecular diagnosis. Sarcoglycan delta (\n                      <jats:italic>SGCD<\/jats:italic>\n                      ) encodes a crucial component of the dystrophin-glycoprotein complex, and variants in this gene have been implicated in both muscular dystrophies and cardiomyopathies.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We evaluated a three-year-old girl presenting with a confirmed diagnosis of DCM. Clinical assessments included echocardiography and cardiac magnetic resonance imaging (CMR), revealing moderate-to-severe systolic and diastolic dysfunction. Whole exome sequencing (WES) was performed to investigate potential causative variants. In silico analysis and Sanger sequencing were used to confirm and characterize any identified alteration in the proband and her parents.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      WES identified a novel heterozygous\n                      <jats:italic>SGCD<\/jats:italic>\n                      variant, NM_000337.6(SGCD): c.647\u00a0A\u2009&gt;\u2009T, p.(Asn216Ile), located in exon 8. Sanger sequencing confirmed this variant\u2019s presence in the proband and her father, suggesting a familial inheritance pattern. In silico predictive tools supported a likely deleterious effect of the variant,, with functional analysis indicating possible disruption of \u03b4-Sarcoglycan\u2019s structure. This variant was absent in public variant databases, underscoring its rarity. Comparative evaluation of known\n                      <jats:italic>SGCD<\/jats:italic>\n                      variants further highlighted exon 8 as a possible mutational hotspot in DCM.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      These findings expand the variant spectrum of\n                      <jats:italic>SGCD<\/jats:italic>\n                      and reinforce its role in familial DCM. Genetic screening for\n                      <jats:italic>SGCD<\/jats:italic>\n                      variants in individuals with idiopathic or familial cardiomyopathy can improve early diagnosis, guide targeted interventions, and inform genetic counseling. Our results underscore the clinical importance of integrating molecular diagnostics to enhance personalized management of DCM.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12920-026-02342-5","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T02:04:21Z","timestamp":1773713061000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["From gene to heart: the impact of a novel SGCD variant in familial dilated cardiomyopathy"],"prefix":"10.1186","volume":"19","author":[{"given":"Samira","family":"Kalayinia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Poopak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdieh","family":"Soveizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Maleki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,17]]},"reference":[{"issue":"10092","key":"2342_CR1","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/S0140-6736(16)31713-5","volume":"390","author":"RG Weintraub","year":"2017","unstructured":"Weintraub RG, Semsarian C, Macdonald P. Dilated cardiomyopathy. Lancet. 2017;390(10092):400\u201314.","journal-title":"Lancet"},{"issue":"1","key":"2342_CR2","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41572-019-0084-1","volume":"5","author":"H-P Schultheiss","year":"2019","unstructured":"Schultheiss H-P, Fairweather D, Caforio AL, Escher F, Hershberger RE, Lipshultz SE, et al. Dilated cardiomyopathy. Nat Rev Dis Primers. 2019;5(1):32.","journal-title":"Nat Rev Dis Primers"},{"issue":"25","key":"2342_CR3","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1016\/j.jacc.2016.03.590","volume":"67","author":"AG Japp","year":"2016","unstructured":"Japp AG, Gulati A, Cook SA, Cowie MR, Prasad SK. The diagnosis and evaluation of dilated cardiomyopathy. J Am Coll Cardiol. 2016;67(25):2996\u20133010.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"2342_CR4","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1001\/jama.2021.24674","volume":"327","author":"GS Huggins","year":"2022","unstructured":"Huggins GS, Kinnamon DD, Haas GJ, Jordan E, Hofmeyer M, Kransdorf E, Ewald GA, Morris AA, Owens A, Lowes B. Prevalence and cumulative risk of familial idiopathic dilated cardiomyopathy. JAMA. 2022;327(5):454\u201363.","journal-title":"JAMA"},{"issue":"7","key":"2342_CR5","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1161\/CIRCRESAHA.116.309396","volume":"121","author":"EM McNally","year":"2017","unstructured":"McNally EM, Mestroni L. Dilated cardiomyopathy: genetic determinants and mechanisms. Circ Res. 2017;121(7):731\u201348.","journal-title":"Circ Res"},{"issue":"1","key":"2342_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1161\/CIRCULATIONAHA.120.053033","volume":"144","author":"E Jordan","year":"2021","unstructured":"Jordan E, Peterson L, Ai T, Asatryan B, Bronicki L, Brown E, Celeghin R, Edwards M, Fan J, Ingles J. Evidence-based assessment of genes in dilated cardiomyopathy. Circulation. 2021;144(1):7\u201319.","journal-title":"Circulation"},{"issue":"1","key":"2342_CR7","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1146\/annurev-med-052422-020535","volume":"75","author":"R Eldemire","year":"2024","unstructured":"Eldemire R, Mestroni L, Taylor MR. Genetics of dilated cardiomyopathy. Annu Rev Med. 2024;75(1):417\u201326.","journal-title":"Annu Rev Med"},{"issue":"9","key":"2342_CR8","doi-asserted-by":"publisher","first-page":"H1140","DOI":"10.1152\/ajpheart.00521.2015","volume":"310","author":"MD Campbell","year":"2016","unstructured":"Campbell MD, Witcher M, Gopal A, Michele DE. Dilated cardiomyopathy mutations in \u03b4-sarcoglycan exert a dominant-negative effect on cardiac myocyte mechanical stability. Am J Physiol Heart Circ Physiol. 2016;310(9):H1140\u201350.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"9","key":"2342_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14093258","volume":"14","author":"S Kumar","year":"2025","unstructured":"Kumar S, Shah G, Nair R, Rikabi S, Seif M, Ghimire B, et al. Characteristics and outcomes of new-onset cardiomyopathy in hospitalized COVID-19 patients. J Clin Med. 2025;14(9):3258.","journal-title":"J Clin Med"},{"issue":"3","key":"2342_CR10","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","volume":"16","author":"S MWer","year":"1988","unstructured":"MWer S, Dykes D, Polesky H. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"2342_CR11","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1111\/jcmm.14887","volume":"24","author":"R Zhang","year":"2020","unstructured":"Zhang R, Chen S, Han P, Chen F, Kuang S, Meng Z, Liu J, Sun R, Wang Z, He X. Whole exome sequencing identified a homozygous novel variant in CEP290 gene causes Meckel syndrome. J Cell Mol Med. 2020;24(2):1906\u201316.","journal-title":"J Cell Mol Med"},{"issue":"2","key":"2342_CR12","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1111\/jcmm.13979","volume":"23","author":"Y Dai","year":"2019","unstructured":"Dai Y, Liang S, Dong X, Zhao Y, Ren H, Guan Y, Yin H, Li C, Chen L, Cui L. Whole exome sequencing identified a novel DAG 1 mutation in a patient with rare, mild and late age of onset muscular dystrophy-dystroglycanopathy. J Cell Mol Med. 2019;23(2):811\u20138.","journal-title":"J Cell Mol Med"},{"issue":"11","key":"2342_CR13","first-page":"887","volume":"16","author":"\u00c7L Baydar","year":"2016","unstructured":"Baydar \u00c7L, \u00d6zen M. A hypertrophic and dilated cardiomyopathic sudden cardiac death case; de novo mutations in TTN and SGCD genes. Anatol J Cardiol. 2016;16(11):887.","journal-title":"Anatol J Cardiol"},{"key":"2342_CR14","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s100480050008","volume":"1","author":"DJ Duggan","year":"1997","unstructured":"Duggan DJ, et al. Mutations in the \u03b4-sarcoglycan gene are a rare cause of autosomal recessive limb-girdle muscular dystrophy (LGMD2). Neurogenetics. 1997;1:49\u201358.","journal-title":"Neurogenetics"},{"issue":"5","key":"2342_CR15","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/ahg.12319","volume":"83","author":"B \u00d6zyilmaz","year":"2019","unstructured":"\u00d6zyilmaz B, et al. Impact of next-generation sequencing panels in the evaluation of limb\u2010girdle muscular dystrophies. Ann Hum Genet. 2019;83(5):331\u201347.","journal-title":"Ann Hum Genet"},{"issue":"6","key":"2342_CR16","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/mgg3.245","volume":"4","author":"N Nouhravesh","year":"2016","unstructured":"Nouhravesh N, et al. Analyses of more than 60,000 exomes questions the role of numerous genes previously associated with dilated cardiomyopathy. Mol Genet Genom Med. 2016;4(6):617\u201323.","journal-title":"Mol Genet Genom Med"},{"issue":"12","key":"2342_CR17","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.nmd.2008.08.003","volume":"18","author":"L Klinge","year":"2008","unstructured":"Klinge L, et al. Sarcoglycanopathies: can muscle immunoanalysis predict the genotype? Neuromuscul Disord. 2008;18(12):934\u201341.","journal-title":"Neuromuscul Disord"},{"issue":"4\u20135","key":"2342_CR18","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0960-8966(00)00100-0","volume":"10","author":"P Dincer","year":"2000","unstructured":"Dincer P, et al. A homozygous nonsense mutation in \u03b4-sarcoglycan exon 3 in a case of LGMD2F. Neuromuscul Disord. 2000;10(4\u20135):247\u201350.","journal-title":"Neuromuscul Disord"},{"issue":"9","key":"2342_CR19","doi-asserted-by":"publisher","first-page":"H1140","DOI":"10.1152\/ajpheart.00521.2015","volume":"310","author":"MD Campbell","year":"2016","unstructured":"Campbell MD, et al. Dilated cardiomyopathy mutations in \u03b4-sarcoglycan exert a dominant-negative effect on cardiac myocyte mechanical stability. Am J Physiol Heart Circ Physiol. 2016;310(9):H1140\u201350.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2342_CR20","doi-asserted-by":"publisher","first-page":"727","DOI":"10.3389\/fgene.2018.00727","volume":"9","author":"M Younus","year":"2019","unstructured":"Younus M, et al. SGCD homozygous nonsense mutation (p. Arg97\u2217) causing limb-girdle muscular dystrophy type 2F (LGMD2F) in a consanguineous family, a case report. Front Genet. 2019;9:727.","journal-title":"Front Genet"},{"issue":"9","key":"2342_CR21","doi-asserted-by":"publisher","first-page":"e006210","DOI":"10.1161\/JAHA.117.006210","volume":"6","author":"C Wang","year":"2017","unstructured":"Wang C, et al. A wide and specific spectrum of genetic variants and genotype\u2013phenotype correlations revealed by next-generation sequencing in patients with left ventricular noncompaction. J Am Heart Association. 2017;6(9):e006210.","journal-title":"J Am Heart Association"},{"issue":"9","key":"2342_CR22","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1038\/ejhg.2009.17","volume":"17","author":"R Bauer","year":"2009","unstructured":"Bauer R, et al. Does \u03b4-sarcoglycan-associated autosomal-dominant cardiomyopathy exist? Eur J Hum Genet. 2009;17(9):1148\u201353.","journal-title":"Eur J Hum Genet"},{"issue":"2","key":"2342_CR23","first-page":"192","volume":"19","author":"R Walsh","year":"2017","unstructured":"Walsh R, et al. Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples. Genet Sci. 2017;19(2):192\u2013203.","journal-title":"Genet Sci"},{"issue":"3","key":"2342_CR24","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1080\/01677063.2017.1346093","volume":"31","author":"A Alavi","year":"2017","unstructured":"Alavi A, et al. LGMD2E is the most common type of sarcoglycanopathies in the Iranian population. J Neurogenet. 2017;31(3):161\u20139.","journal-title":"J Neurogenet"},{"issue":"5","key":"2342_CR25","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1136\/jmg.40.5.e67","volume":"40","author":"C Boito","year":"2003","unstructured":"Boito C, et al. Novel sarcoglycan gene mutations in a large cohort of Italian patients. J Med Genet. 2003;40(5):e67\u201367.","journal-title":"J Med Genet"},{"key":"2342_CR26","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ijcard.2017.10.016","volume":"250","author":"JT Leinonen","year":"2018","unstructured":"Leinonen JT, et al. The genetics underlying idiopathic ventricular fibrillation: a special role for catecholaminergic polymorphic ventricular tachycardia? Int J Cardiol. 2018;250:139\u201345.","journal-title":"Int J Cardiol"},{"issue":"8","key":"2342_CR27","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1093\/hmg\/5.8.1179","volume":"5","author":"V Nigro","year":"1996","unstructured":"Nigro V, et al. Identification of a novel sarcoglycan gene at 5q33 encoding a sarcolemmal 35\u00a0kDa glycoprotein. Hum Mol Genet. 1996;5(8):1179\u201386.","journal-title":"Hum Mol Genet"},{"issue":"11","key":"2342_CR28","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1136\/jmg.35.11.951","volume":"35","author":"ES Moreira","year":"1998","unstructured":"Moreira ES, et al. A first missense mutation in the delta sarcoglycan gene associated with a severe phenotype and frequency of limb-girdle muscular dystrophy type 2F (LGMD2F) in Brazilian sarcoglycanopathies. J Med Genet. 1998;35(11):951\u20133.","journal-title":"J Med Genet"},{"issue":"12","key":"2342_CR29","doi-asserted-by":"publisher","first-page":"e0145602","DOI":"10.1371\/journal.pone.0145602","volume":"10","author":"J Chen","year":"2015","unstructured":"Chen J, et al. A haplotype of two novel polymorphisms in \u03b4-Sarcoglycan gene increases risk of dilated cardiomyopathy in Mongoloid population. PLoS One. 2015;10(12):e0145602.","journal-title":"PLoS One"},{"key":"2342_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-018-0859-6","volume":"13","author":"L Wang","year":"2018","unstructured":"Wang L, et al. The clinical spectrum and genetic variability of limb-girdle muscular dystrophy in a cohort of Chinese patients. Orphanet J Rare Dis. 2018;13:1\u201314.","journal-title":"Orphanet J Rare Dis"},{"issue":"17","key":"2342_CR31","doi-asserted-by":"publisher","first-page":"27812","DOI":"10.18632\/oncotarget.15434","volume":"8","author":"J Li","year":"2017","unstructured":"Li J, et al. Whole-exome sequencing identifies SGCD and ACVRL1 mutations associated with total anomalous pulmonary venous return (TAPVR) in Chinese population. Oncotarget. 2017;8(17):27812.","journal-title":"Oncotarget"},{"issue":"11","key":"2342_CR32","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3390\/genes9110524","volume":"9","author":"T Giugliano","year":"2018","unstructured":"Giugliano T, et al. Copy number variants account for a tiny fraction of undiagnosed myopathic patients. Genes. 2018;9(11):524.","journal-title":"Genes"},{"key":"2342_CR33","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s00439-017-1821-8","volume":"136","author":"D Monies","year":"2017","unstructured":"Monies D, et al. The landscape of genetic diseases in Saudi Arabia based on the first 1000 diagnostic panels and exomes. Hum Genet. 2017;136:921\u201339.","journal-title":"Hum Genet"},{"issue":"8","key":"2342_CR34","first-page":"601","volume":"16","author":"TJ Pugh","year":"2014","unstructured":"Pugh TJ, et al. The landscape of genetic variation in dilated cardiomyopathy as surveyed by clinical DNA sequencing. Genet Sci. 2014;16(8):601\u20138.","journal-title":"Genet Sci"},{"issue":"2","key":"2342_CR35","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/ng1096-195","volume":"14","author":"V Nigro","year":"1996","unstructured":"Nigro V, et al. Autosomal recessive limbgirdle muscular dystrophy, LGMD2F, is caused by a mutation in the \u03b4\u2013sarcoglycan gene. Nat Genet. 1996;14(2):195\u20138.","journal-title":"Nat Genet"},{"issue":"12","key":"2342_CR36","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1002\/acn3.649","volume":"5","author":"BRR Nallamilli","year":"2018","unstructured":"Nallamilli BRR, et al. Genetic landscape and novel disease mechanisms from a large LGMD cohort of 4656 patients. Ann Clin Transl Neurol. 2018;5(12):1574\u201387.","journal-title":"Ann Clin Transl Neurol"},{"issue":"8","key":"2342_CR37","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.3390\/genes14081641","volume":"14","author":"B Brunetti","year":"2023","unstructured":"Brunetti B, et al. SGCD Missense Variant in a Lagotto Romagnolo Dog with Autosomal Recessively Inherited Limb-Girdle Muscular Dystrophy. Genes. 2023;14(8):1641.","journal-title":"Genes"},{"issue":"5","key":"2342_CR38","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1172\/JCI9224","volume":"106","author":"S Tsubata","year":"2000","unstructured":"Tsubata S, et al. Mutations in the human \u03b4-sarcoglycan gene in familial and sporadic dilated cardiomyopathy. J Clin Investig. 2000;106(5):655\u201362.","journal-title":"J Clin Investig"},{"issue":"2","key":"2342_CR39","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1093\/brain\/awab301","volume":"145","author":"J Alonso-P\u00e9rez","year":"2022","unstructured":"Alonso-P\u00e9rez J, et al. Clinical and genetic spectrum of a large cohort of patients with \u03b4-sarcoglycan muscular dystrophy. Brain. 2022;145(2):596\u2013606.","journal-title":"Brain"},{"issue":"4","key":"2342_CR40","doi-asserted-by":"publisher","first-page":"406","DOI":"10.4103\/0028-3886.55603","volume":"57","author":"SV Khadilkar","year":"2009","unstructured":"Khadilkar SV, et al. Spectrum of mutations in sarcoglycan genes in the Mumbai region of western India: high prevalence of 525del T. Neurol India. 2009;57(4):406\u201310.","journal-title":"Neurol India"},{"issue":"1","key":"2342_CR41","doi-asserted-by":"publisher","first-page":"21547","DOI":"10.1038\/s41598-023-48982-w","volume":"13","author":"S Sarker","year":"2023","unstructured":"Sarker S, et al. Mutational spectrum and phenotypic variability of Duchenne muscular dystrophy and related disorders in a Bangladeshi population. Sci Rep. 2023;13(1):21547.","journal-title":"Sci Rep"},{"issue":"5","key":"2342_CR42","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1172\/JCI9224","volume":"106","author":"S Tsubata","year":"2000","unstructured":"Tsubata S, Bowles KR, Vatta M, Zintz C, Titus J, Muhonen L, et al. Mutations in the human \u03b4-sarcoglycan gene in familial and sporadic dilated cardiomyopathy. J Clin Invest. 2000;106(5):655\u201362.","journal-title":"J Clin Invest"},{"issue":"4\u20135","key":"2342_CR43","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0960-8966(00)00100-0","volume":"10","author":"P Dincer","year":"2000","unstructured":"Dincer P, B\u00f6nnemann C, Aker \u00d6E, Ak\u00e7\u00f6ren Z, Nigro V, Kunkel L, Topalo\u011flu H. A homozygous nonsense mutation in \u03b4-sarcoglycan exon 3 in a case of LGMD2F. Neuromuscul Disord. 2000;10(4\u20135):247\u201350.","journal-title":"Neuromuscul Disord"},{"key":"2342_CR44","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s100480050008","volume":"1","author":"DJ Duggan","year":"1997","unstructured":"Duggan DJ, Manchester D, Stears KP, Mathews DJ, Hart C, Hoffman EP. Mutations in the \u03b4-sarcoglycan gene are a rare cause of autosomal recessive limb-girdle muscular dystrophy (LGMD2). Neurogenetics. 1997;1:49\u201358.","journal-title":"Neurogenetics"},{"issue":"9","key":"2342_CR45","doi-asserted-by":"publisher","first-page":"H1140","DOI":"10.1152\/ajpheart.00521.2015","volume":"310","author":"MD Campbell","year":"2016","unstructured":"Campbell MD, Witcher M, Gopal A, Michele DE. Dilated cardiomyopathy mutations in \u03b4-sarcoglycan exert a dominant-negative effect on cardiac myocyte mechanical stability. Am J Physiol Heart Circ Physiol. 2016;310(9):H1140\u20131150.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2342_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2018.00727","volume":"9","author":"M Younus","year":"2019","unstructured":"Younus M, Ahmad F, Malik E, Bilal M, Kausar M, Abbas S, et al. SGCD homozygous nonsense mutation (p. Arg97\u2217) causing limb-girdle muscular dystrophy type 2F (LGMD2F) in a consanguineous family, a case report. Front Genet. 2019;9:727.","journal-title":"Front Genet"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-026-02342-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-026-02342-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-026-02342-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:15:00Z","timestamp":1781640900000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12920-026-02342-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2342"],"URL":"https:\/\/doi.org\/10.1186\/s12920-026-02342-5","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,17]]},"assertion":[{"value":"14 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our study adhered to the Declaration of Helsinki and was approved by the Ethics Committee of Rajaie Cardiovascular Institute, Tehran, Iran (IR.RHC.REC.1404.087). Informed consent to participate was obtained from the parents or legal guardians of any participant under the age of 16 and clearly state this in your manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent for publication of clinical details and\/or clinical images was obtained from the parents of the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"67"}}